Episurf Medical AB Series B
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesio… Read more
Market Cap & Net Worth: Episurf Medical AB Series B (0QUT)
Episurf Medical AB Series B (LSE:0QUT) has a market capitalization of $46.05 (Skr516.62) as of March 18, 2026. Listed on the LSE stock exchange, this UK-based company holds position #30924 globally and #473 in its home market, demonstrating a 36.88% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Episurf Medical AB Series B's stock price Skr0.05 by its total outstanding shares 9803 (9.80K).
Episurf Medical AB Series B Market Cap History: 2026 to 2026
Episurf Medical AB Series B's market capitalization history from 2026 to 2026. Data shows growth from $56.45 to $56.45 (0.00% CAGR).
Episurf Medical AB Series B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Episurf Medical AB Series B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 0QUT by Market Capitalization
Companies near Episurf Medical AB Series B in the global market cap rankings as of March 18, 2026.
Key companies related to Episurf Medical AB Series B by market ranking:
- Focus Graphite Inc (OTCQB:FCSMF): Ranked #30915 globally with a market cap of $5.48 Million USD.
- Baltic Sea Properties AS (OL:BALT): Ranked #30916 globally with a market cap of $5.48 Million USD ( Nkr62.40 Million NOK).
- Bulletin Resources Ltd (AU:BNR): Ranked #30925 globally with a market cap of $5.46 Million USD ( AU$8.81 Million AUD).
- ALSAF (PINK:ALSAF): Ranked #30926 globally with a market cap of $5.46 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #30915 | Focus Graphite Inc | OTCQB:FCSMF | $5.48 Million | $0.06 |
| #30916 | Baltic Sea Properties AS | OL:BALT | $5.48 Million | Nkr46.60 |
| #30925 | Bulletin Resources Ltd | AU:BNR | $5.46 Million | AU$0.05 |
| #30926 | ALSAF | PINK:ALSAF | $5.46 Million | $15.47 |
Episurf Medical AB Series B Historical Marketcap From 2026 to 2026
Between 2026 and today, Episurf Medical AB Series B's market cap moved from $56.45 to $ 56.45, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr56.45 | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Episurf Medical AB Series B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $46.05 USD |
| MoneyControl | $46.05 USD |
| MarketWatch | $46.05 USD |
| marketcap.company | $46.05 USD |
| Reuters | $46.05 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.